Catalyst Pharmaceuticals, Inc. Financial Ratios — CPRX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	83.35	80.6	56.43
Return on Assets (%)	-105.81	-35.39	-57.66	-44.77	-38.91	-35.5	-28.97	-46.63	36.89	49.21	18.36	27.09	16.89	24.8	21.92
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	43.1	- -	20.63	30.83	18.6	26.31	23.06
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	100	85.57	85.69	84.46	83.94	86.95	86	85.19
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	-7,051.44	31.16	34.76	37.33	48.12	30.06	47.36	50.2
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	-7,059.03	31.11	34.69	37.2	47.54	21.8	39.68	43.77
Incremental Operating Margin (%)	420.89	- -	- -	- -	- -	- -	- -	- -	65.93	56.54	50.93	67.4	-8.17	115.8	64.42
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	-6,800.7	32.66	35.18	37.4	48.89	23.73	43.98	48.14
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	-6,800.7	31.16	62.97	28.03	38.79	17.93	33.33	36.39
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	-6,800.7	31.16	62.97	28.03	38.79	17.93	33.33	36.39
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	4.59	- -	25.03	20.66	24.44	24.22	24.4
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	83.35	80.6	56.43

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	4	4	4	3	3
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	4	4	3	3	2
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	0.03	- -	0.08	0.04	0.03	0.01	0.01
Net Debt/EBITDA	1	0.27	0.22	0.62	1.39	0.72	3.09	0.47	-2.81	-3.15	-3.26	-2.89	-1.15	-2.22	-2.4
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	0.03	- -	0.08	0.04	0.04	0.02	0.01
Net Debt/EBIT	0.99	0.27	0.21	0.62	1.38	0.72	3.08	0.47	-2.81	-3.15	-3.27	-2.93	-1.59	-2.65	-2.75
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-609.32	-250.98	-213.96	-158.91	-149.73	-259.11	-148.1	-265.44	-114.42	-27.87	-11.02	13.3	25.82	33.51	42.96
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.74	- -	1.88	1.18	0.82	0.38	0.25
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-0.51	- -	-17.7	6.6	2.55	0.97	0.49
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.58	- -	1.64	0.95	0.68	0.33	0.21
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.08	0.02	2.03	1.3	0.92	0.44	0.29
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-0.74	-0.05	-19.1	7.23	2.85	1.11	0.58
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.84	0.02	1.77	1.04	0.76	0.37	0.25
Net Debt to Equity	-160.32	-9.64	-10.36	-25.81	-50.9	-35.34	-71.02	-32.61	-102.15	-76.79	-82.89	-99.33	-35.48	-71.13	-74.32
Net Debt/Capital (%)	13.67	3.24	3.92	11.53	23.88	11.39	31.26	9.35	41.22	70.85	88.62	122.03	1,083.75	225.92	305.58
EBITDA	-6	-5	-10	-15	-20	-19	-19	-35	32	41	53	103	120	233	296
EBITDA-CapEx	-6	-5	-10	-15	-20	-19	-19	-35	32	41	52	103	38	232	296
Operating Income (Loss)	-6	-5	-10	-15	-20	-19	-19	-35	32	41	52	102	87	195	258

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	7.23	9.36	11.08	6.71	16.97	19.29	19.69	5.62	3.92	6.16	7.07	5.18	1.81	4.29	4.82
Current Ratio	7.47	10.16	11.83	7.49	17.41	19.79	19.97	5.8	4.62	7	7.76	5.57	2.88	5.17	6.08
Quick Ratio	7.23	9.36	11.08	6.71	16.97	19.29	19.69	5.62	4.36	6.45	7.32	5.37	2.51	4.84	5.69
CFO/Avg Current Liab	-8.8	-4.14	-5.22	-3.24	-3.88	-6.49	-4.32	-3.8	2.06	1.92	2.42	2.74	2.15	2.44	1.56
Common Equity/Total Assets	-609.32	-250.98	-213.96	-158.91	-149.73	-259.11	-148.1	-265.44	-114.42	-27.87	-11.02	13.3	25.82	33.51	42.96
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.74	- -	1.88	1.18	0.82	0.38	0.25
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-0.51	- -	-17.7	6.6	2.55	0.97	0.49
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.58	- -	1.64	0.95	0.68	0.33	0.21
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.08	0.02	2.03	1.3	0.92	0.44	0.29
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-0.74	-0.05	-19.1	7.23	2.85	1.11	0.58
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.84	0.02	1.77	1.04	0.76	0.37	0.25
CFO/Total Liabilities	-200.32	-237.2	-248.24	-149.34	-389.5	-749.13	-310.66	-270.51	139.87	197.9	195.02	154.3	174.63	193.74	139.38
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	-284.16	1,821.68	4,094	59.13	4,001.62	1.76	431.31	3,597.76
Altman's Z-Score	-3.95	0.15	10.12	10.9	23.61	17.75	43.84	7.5	10.53	10.9	15.65	18.07	16.75	15.06	14.52

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	19.42	14.41	22.34	25.11	12.45	8.27	6.14
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	18.8	25.33	16.34	14.53	29.31	44.16	59.48
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	14.67	5.16	3.5	4.69	4.63	3.91	3.08
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	24.89	70.77	104.42	77.87	78.84	93.27	118.61
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	0.03	5.16	4.71	7.15	9.89	6.48	4.64	7.55
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	13,954.81	70.71	77.44	51.06	36.92	56.34	78.75	48.37
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	-27.02	18.66	69.69	55.48	51.81	58.68	129.72
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	-6.09	-45.45	-88.08	-63.34	-49.53	-49.11	-59.13
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	2	5	8	7	16	20	37
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	- -	2	7	17
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	4	5	6	5	3	4
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	9	10	16
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	2	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	28	13	89	191	198	87	335	197	386	346	700	1,923	1,787	2,472	2,854
- Cash & Cash Equivalents	6	1	2	9	28	14	57	17	90	130	171	298	138	518	709
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	4	4	4	3	3
Enterprise Value	22	-2	65	151	140	47	251	144	292	205	513	1,628	1,652	1,958	2,148
Total Capital	-38	-42	-54	-70	-90	-108	-126	-160	-128	-54	-22	54	125	288	477
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-0.74	-0.05	-19.1	7.23	2.85	1.11	0.58
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.01	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	287.15	2.86	1.73	3.64	7.6	4.15	3.98	3.65
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	9.17	4.96	9.75	15.8	13.81	8.41	7.26
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	9.19	4.98	9.79	15.99	19.04	10.03	8.33
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	8.45	4.56	8.49	14.03	11.51	8.16	10.29
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	8.45	4.56	8.35	14.03	7.33	8.15	10.29
Diluted Market Cap	28	13	89	191	198	87	335	197	398	355	730	2,072	1,912	2,608	2,970
Diluted Enterprise Value	22	12	86	181	170	73	278	180	309	225	563	1,777	1,778	2,093	2,264
EV per Share	1.01	- -	1.43	2.36	1.73	0.56	2.93	1.4	2.84	1.99	4.96	15.75	15.55	16.53	17.56
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	102	119	141	214	398	492	589
TTM EBITDA	-6	-5	-10	-15	-20	-19	-19	-35	32	41	53	103	120	233	296
TTM Operating Income	-6	-5	-10	-15	-20	-19	-19	-35	32	41	52	102	87	195	258
TTM Cash Flow to Firm	-5	-5	-10	-13	-18	-18	-14	-26	35	45	60	116	144	240	209
TTM Free Cash Flow to Firm	-5	-5	-10	-13	-18	-18	-14	-26	35	45	61	116	225	240	209

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-5.62	-2.54	-8.97	-14.72	-11	-4.84	-24.41	-7.56	11.48	7.88	11.89	17.85	8.49	10.85	14.23
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	9.19	4.98	9.79	15.99	19.04	10.03	8.33
Enterprise Value	22	-2	65	151	140	47	251	144	292	205	513	1,628	1,652	1,958	2,148
Low Price	0.9	0.37	0.41	1.7	2.27	0.51	1.02	1.85	1.85	2.55	3.27	5.24	11.09	13.12	19.05
EV/Sales	- -	- -	- -	- -	- -	- -	- -	287.15	2.86	1.73	3.64	7.6	4.15	3.98	3.65
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	9.17	4.96	9.75	15.8	13.81	8.41	7.26
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	12.11	4.61	17.73	23.14	25.02	15.08	13.32
Price/Earnings Average	-4.36	-7.74	-4.73	-9.93	-14.76	-5.02	-10.98	-9.31	13.99	5.47	13.9	13	21.54	12.8	12.68
Price/Earnings High	-7.65	-16.72	-13.65	-14.43	-23.18	-11.19	-21.02	-12.31	24.77	7.29	19.85	24.61	32.91	17.54	15.17
Price/Earnings Low	-3.06	-2.73	-1.54	-7.03	-9.07	-2.34	-4.75	-5.58	5.97	3.52	8.56	6.52	16.51	9.48	10.87
Price/Book Value	-0.74	-0.31	-1.63	-2.73	-2.2	-0.81	-2.65	-1.23	-3	-6.45	-26.71	38.48	14.72	8.67	6.02
Price/Book Value Average	-0.73	-0.75	-1.06	-2.21	-3.32	-0.84	-1.6	-1.97	-3.47	-7.65	-20.95	21.61	12.68	7.35	5.73
Price/Book Value High	-1.28	-1.62	-3.06	-3.21	-5.21	-1.87	-3.06	-2.61	-6.14	-10.2	-29.9	40.92	19.36	10.08	6.85
Price/Book Value Low	-0.51	-0.26	-0.34	-1.56	-2.04	-0.39	-0.69	-1.18	-1.48	-4.92	-12.9	10.84	9.71	5.45	4.91
Price/Tangible Book Value	7.45	0.89	4.14	5.41	3.57	2.21	4.14	3.88	4.41	2.04	3.38	7.18	9.22	4.33	3.47
Price/Tangible Book Value Average	7.4	2.16	2.69	4.37	5.38	2.31	2.5	6.24	5.09	2.42	2.65	4.03	7.94	3.67	3.3
Price/Tangible Book Value High	13	4.66	7.76	6.35	8.45	5.14	4.78	8.25	9.01	3.22	3.79	7.63	12.12	5.04	3.95
Price/Tangible Book Value Low	5.2	0.76	0.87	3.09	3.31	1.08	1.08	3.74	2.17	1.56	1.63	2.02	6.08	2.72	2.83
Price/Sales	- -	- -	- -	- -	- -	- -	- -	394.11	3.77	2.9	4.97	8.98	4.49	5.03	4.85
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	633.48	4.36	3.45	3.9	5.04	3.86	4.26	4.61
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	837.49	7.72	4.59	5.56	9.55	5.9	5.85	5.52
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	379.75	1.86	2.22	2.4	2.53	2.96	3.16	3.96
Price/Cash Flow	-5.62	-2.54	-8.97	-14.72	-11	-4.84	-24.41	-7.54	11.15	7.68	11.59	16.57	12.44	10.31	13.68
Price/Cash Flow Average	-5.59	-6.14	-5.82	-11.9	-16.57	-5.05	-14.71	-12.11	12.88	9.11	9.09	9.3	10.71	8.75	13.03
Price/Cash Flow High	-9.81	-13.26	-16.8	-17.3	-26.03	-11.26	-28.16	-16.01	22.81	12.14	12.98	17.62	16.36	11.99	15.58
Price/Cash Flow Low	-3.92	-2.16	-1.89	-8.43	-10.19	-2.35	-6.37	-7.26	5.5	5.86	5.6	4.67	8.21	6.48	11.16
Price/Free Cash Flow Average	-5.59	-6.14	-5.82	-11.9	-16.57	-5.05	-14.71	-12.16	13.26	9.35	9.32	10.02	7.31	9.2	13.55
Price/Free Cash Flow High	-9.81	-13.26	-16.8	-17.3	-26.03	-11.26	-28.16	-16.07	23.48	12.45	13.31	18.98	11.16	12.62	16.21
Price/Free Cash Flow Low	-3.92	-2.16	-1.89	-8.43	-10.19	-2.35	-6.37	-7.29	5.66	6.01	5.74	5.03	5.6	6.82	11.61
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	600.36	3.49	2.35	2.71	3.67	3.53	3.22	3.42
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	804.37	6.85	3.5	4.38	8.17	5.56	4.8	4.32
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	346.63	1	1.12	1.21	1.15	2.62	2.11	2.76
EV/EBITDA Average	-3.61	-5.78	-5.37	-9.95	-13.28	-3.99	-7.76	-8.51	11.21	6.77	7.26	7.62	11.73	6.8	6.8
EV/EBITDA High	-7.1	-12.81	-15.91	-14.75	-21.64	-9.79	-17.68	-11.41	21.99	10.06	11.72	16.98	18.51	10.14	8.61
EV/EBITDA Low	-2.24	-1.86	-1.6	-6.86	-7.63	-1.47	-1.61	-4.92	3.2	3.23	3.25	2.4	8.73	4.46	5.49
EV/EBIT Average	-3.59	-5.77	-5.36	-9.93	-13.25	-3.98	-7.75	-8.5	11.23	6.78	7.29	7.71	16.18	8.11	7.8
EV/EBIT High	-7.05	-12.79	-15.87	-14.72	-21.61	-9.77	-17.64	-11.39	22.03	10.08	11.77	17.19	25.52	12.1	9.87
EV/EBIT Low	-2.23	-1.86	-1.6	-6.85	-7.61	-1.47	-1.61	-4.91	3.2	3.24	3.26	2.43	12.03	5.33	6.3
Last Price	1.29	0.44	1.95	2.97	2.45	1.05	3.91	1.92	3.75	3.34	6.77	18.6	16.81	20.87	23.34
High Price	2.25	2.27	3.65	3.49	5.8	2.44	4.51	4.08	7.67	5.28	7.58	19.78	22.11	24.27	26.58
Enterprise Value Average	22	30	55	145	270	77	145	300	357	280	382	785	1,404	1,583	2,012
Enterprise Value High	43	67	164	215	441	188	329	402	701	416	616	1,750	2,216	2,361	2,544
Enterprise Value Low	14	10	16	100	155	28	30	173	102	134	171	247	1,045	1,040	1,623

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	25	41	54	69	83	83	103	103	103	104	103	105	107	121	123
Diluted Weighted Avg Shares	22	30	45	64	81	83	86	103	106	106	108	111	114	125	127
Basic Weighted Avg Shares	22	30	45	64	81	83	86	103	103	104	103	103	106	118	122
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	0.99	1.15	1.36	2.07	3.75	4.15	4.82
EBITDA per Share	-0.28	-0.17	-0.23	-0.23	-0.25	-0.23	-0.22	-0.34	0.31	0.4	0.51	1	1.13	1.97	2.42
Operating Income per Share	-0.28	-0.17	-0.23	-0.23	-0.25	-0.23	-0.22	-0.34	0.31	0.4	0.51	0.99	0.82	1.65	2.11
Basic EPS, GAAP	-0.29	-0.14	-0.27	-0.24	-0.25	-0.22	-0.21	-0.33	0.31	0.72	0.38	0.8	0.67	1.38	1.75
Basic EPS from Cont Ops	-0.29	-0.14	-0.27	-0.24	-0.25	-0.22	-0.21	-0.33	0.31	0.72	0.38	0.8	0.67	1.38	1.75
Diluted EPS, GAAP	-0.29	-0.14	-0.27	-0.24	-0.25	-0.22	-0.21	-0.33	0.3	0.71	0.37	0.75	0.63	1.31	1.68
Diluted EPS from Cont Ops	-0.29	-0.14	-0.27	-0.24	-0.25	-0.22	-0.21	-0.33	0.3	0.71	0.37	0.75	0.63	1.31	1.68
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.23	-0.17	-0.22	-0.2	-0.22	-0.22	-0.16	-0.25	0.34	0.44	0.58	1.12	1.35	2.02	1.71
Free Cash Flow per Basic Share	-0.23	-0.17	-0.22	-0.2	-0.22	-0.22	-0.16	-0.26	0.34	0.43	0.57	1.12	0.58	2.02	1.71
Cash & Equivalents per Share	0.28	0.51	0.52	0.61	0.72	0.49	0.98	0.52	0.92	1.36	1.85	2.89	1.3	4.37	5.8
Book Value per Share	-1.75	-1.4	-1.19	-1.09	-1.11	-1.3	-1.47	-1.56	-1.25	-0.52	-0.25	0.48	1.14	2.41	3.88
Tangible Book Value per Share	0.17	0.49	0.47	0.55	0.69	0.47	0.94	0.49	0.85	1.64	2	2.59	1.82	4.82	6.73

Catalyst Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)